Consistent with our findings, FGFR signaling has been shown to enhance IFN-γ-induced PD-L1 expression via glycosylation, while FGFR inhibitors suppressed PD-L1 induction in head and neck squamous cell carcinoma [41]. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.